32.30SEK+0.31%Mkt Cap: 50.36M $P/E: —Today
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in …